Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Electrona ORS is a ready-to-drink oral rehydration solution (ORS) developed and marketed by Lagap. Formulated in accordance with World Health Organization (WHO) guidelines, it contains a balanced mixture of anhydrous glucose, potassium chloride, sodium chloride, and trisodium citrate. It is indicated for the prevention and treatment of dehydration by replenishing essential fluids and electrolytes lost due to conditions such as diarrhea, vomiting, excessive sweating, physical exertion, or high temperatures. Electrona ORS is available in convenient 200ml tetra packs in flavors like orange and green apple, making it highly palatable and easy to administer to both children and adults.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Electrona ORS.